FEATURES OF THE CONDITION OF NEWBORNS FROM PREGNANT WOMEN WITH POST-COVID SYNDROME
DOI:
https://doi.org/10.11603/24116-4944.2024.2.15063Keywords:
post-covid syndrome, gestation, fetus, fetal growth retardation syndrome, spontaneous preterm birth, premature rupture of the amniotic membraneAbstract
The aim of the study was to study the impact of post-covid syndrome on the course of pregnancy and the condition of the newborn.
Materials and Methods. The study involved 60 pregnant women (main group) with SARS-CoV-2 transmission, positive Ig A, M or G to SARS-CoV-2 at 30-34 weeks of gestation from November 2020 to January 2022. The control group consisted of 30 women with physiological pregnancy. We investigated the frequency of detected complications during pregnancy and the features of the course of pregnancy with associated pathology. The condition of the fetus was assessed according to ultrasound data of the pregnant woman, determination of the biophysical profile and Doppler results.
Results and Discussion. Among all the complications observed in women with acute respiratory disease during pregnancy, the following were observed: premature birth – 5 cases (8.8 %), oligohydramnios – 2 cases (3.5 %), exacerbation of chronic pyelonephritis – 2 cases (3.5 %), acute pyelonephritis first detected during pregnancy – 1 case (1.7 %), polyhydramnios – 1 case (1.7 %), moderate preeclampsia – 1 case (1.7 %), severe preeclampsia – 1 case (1.7 %), premature detachment of a normally located placenta – 1 case (1.7 %). Among pregnant women with SARS-CoV-2, 15 (26.3 %) women (OR=7.1; 95 % CI: 1.21–13.2; P<0.01) had severe fetoplacental blood flow abnormalities in the fetal umbilical artery (compared to the control group). Fetal growth retardation was diagnosed in 26 pregnant women (45.6 %) (OR = 20.4; 95 % CI: 2.56–16.3; P<0.01). Six pregnant women (10.5 %) (OR=1.5; 95 % CI: 1.01–3.12; P<0.01) had high-resistance blood flow without a diastolic component, indicating a threatening condition and fetal distress syndrome, detected by Doppler. The presence of pathological processes in the fetoplacental complex negatively affected the condition of the fetus, led to growth retardation, which led to an increased risk of perinatal mortality. According to ultrasound, 26 pregnant women were diagnosed with fetal growth retardation, which is 45.6 percent of all those examined in the main group, and 43 pregnant women (75.4 %) had certain pathological changes in the placenta.
Conclusions. Thus, we can conclude that in children born to mothers with post-covid syndrome, an increase in the frequency of pathological course of the early neonatal period was recorded. COVID-19 during pregnancy was associated with increased maternal morbidity and neonatal complications. Fetal post-covid syndrome was observed, accompanied by growth retardation syndrome, distress, antenatal fetal death and increased thrombosis in the vessels of the placenta and umbilical cord.
References
Blitz, M.J., Gerber, R.P., et al. (2021). Preterm birth among women with and without severe acute respiratory syndrome coronavirus 2 infection. Acta Obstetricia et Gynecologica Scandinavica, 100(12), 2253-2259. DOI: https://doi.org/10.1111/aogs.14269
Di Toro, F., Gjoka, M., Di Lorenzo, G., et al. (2021). Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect., 27(1), 36-46. DOI: https://doi.org/10.1016/j.cmi.2020.10.007
Einarsdóttir, K., Swift, E.M., Zoega, H. (2021). Changes in obstetric interventions and preterm birth during COVID-19: A nationwide study from Iceland. Acta Obstetricia et Gynecologica Scandinavica, 100(10), 1924-1930. DOI: https://doi.org/10.1111/aogs.14231
Facciolà, A., Micali, C., Visalli, G., et al. (2022). COVID-19 and pregnancy: clinical outcomes and scientific evidence about vaccination. Eur Rev Med Pharmacol Sci., 26(7), 2610-2626.
Keskin, A., Ustun, G., Aci, R, Duran, U. (2022). Homocysteine as a marker for predicting disease severity in patients with COVID-19. Biomark Med., 16(7), 559-568. DOI: https://doi.org/10.2217/bmm-2021-0688
Castro, P., Matos, A.P., Werner, H., Lopes, F.P., Tonni, G., Júnior, A.J.J. (2020). Covid-19 and pregnancy: an overview. Rev Bras Ginecol Obstet., 42(7), 420-426. DOI: https://doi.org/10.1055/s-0040-1713408
Mirbeyk, M., Saghazadeh, A., Rezaei, N. (2021). A systematic review of pregnant women with COVID-19 and their neonates. Arch Gynecol Obstet., 304(1), 5-38. DOI: https://doi.org/10.1007/s00404-021-06049-z
Mulvey, J.J., Magro C.M., Ma, L.X., Nuovo, G.J., Baergen, R.N. (2020). Analysis of complement deposition and viral RNA in placentas of COVID-19 patients. Ann Diagn Pathol., 46, 151530. DOI: https://doi.org/10.1016/j.anndiagpath.2020.151530
Aabakke, A.J.M., Petersen, T.G. et al. (2023). Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis. Acta Obstetricia et Gynecologica Scandinavica, 102(3), 282-293. DOI: https://doi.org/10.1111/aogs.14512
Aimes, R.T., Zijlstra, A., Hooper, J.D., et al. (2003). Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb Haemost., 89(3), 561-572. DOI: https://doi.org/10.1055/s-0037-1613388
Alzamora, M.C., Paredes, T., Caceres, D., Webb, C.M., Valdez, L.M., La Rosa, M. (2020). Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol., 37(8), 861-865. DOI: https://doi.org/10.1055/s-0040-1710050
Bikdeli, B., Madhavan, M.V., Gupta, A., et al. (2020). Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemost., 120(7), 1004-1024. DOI: https://doi.org/10.1055/s-0040-1713152
Dashraath, P., Wong, J.L.J., Lim, M.X.K., et al. (2020). Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol., 222(6), 521-531. DOI: https://doi.org/10.1016/j.ajog.2020.03.021
Guo, D., Lv, Y., Qi, Y., Pan, S. (2020). Increased circulating microparticles and inflammatory factors aggravate coronavirus disease 2019 (COVID-19). Res Square, 2020. DOI: 10.21203/rs.3.rs-19182/v1. DOI: https://doi.org/10.21203/rs.3.rs-19182/v1
Kant Sahu, K., Lal, A., Kumar Mishra, A. (2020). COVID-2019 and pregnancy: A plea for transparent reporting of all cases. Acta Obstetricia et Gynecologica Scandinavica, 99(7), 951. DOI: https://doi.org/10.1111/aogs.13850
Schwartz, D.A. (2020). An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med., 144(7), 799-805. DOI: https://doi.org/10.5858/arpa.2020-0901-SA
Zaigham, M., Andersson, O. (2020). Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand., 99(7), 823-829. DOI: https://doi.org/10.1111/aogs.13867
Serrano, B., Mendoza, M. et al. (2020). Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational study. Acta Obstetricia et Gynecologica Scandinavica, 101(7), 803-808. DOI: https://doi.org/10.1111/aogs.14371
Muyayalo, K.P., Huang, D.H., Zhao, S.J., Xie, T., Mor, G., Liao, A.H. (2020). COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes. Am J Reprod Immunol., 84(5), e13304. DOI: https://doi.org/10.1111/aji.13304
Narang, K., Enninga, E.A.L., Gunaratne, M.D.S.K., et al. (2020). SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clin Proc., 95(8), 1750-1765. DOI: https://doi.org/10.1016/j.mayocp.2020.05.011
Rizzo, G., Mappa, I. et al. (2021). Effect of SARS-CoV-2 infection during the second half of pregnancy on fetal growth and hemodynamics: a prospective study. Acta Obstetricia et Gynecologica Scandinavica, 100(6), 1034-1039. DOI: https://doi.org/10.1111/aogs.14130
Severinsen, E.R., Kähler, L.K.A. et al. (2021). Mental health indicators in pregnant women compared with women in the general population during the coronavirus disease 2019 pandemic in Denmark. Acta Obstetricia et Gynecologica Scandinavica., 100(11), 2009-2018. DOI: https://doi.org/10.1111/aogs.14258
Vergara-Merino, L., Meza, N. et al. (2021). Maternal and perinatal outcomes related to COVID-19 and pregnancy: An overview of systematic reviews. Acta Obstetricia et Gynecologica Scandinavica, 100(7), 1200-1218. DOI: https://doi.org/10.1111/aogs.14118
Wastnedge, E.A.N., Reynolds, R.M., van Boeckel, S.R. (2021). Pregnancy and COVID-19. Physiol Rev, 101(1), 303-318. DOI: https://doi.org/10.1152/physrev.00024.2020
Rasmussen, S.A., Kelley, C.F., Horton, J.P., Jamieson, D.J. (2021). Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Obstet Gynecol., 137(3), 408-414. DOI: https://doi.org/10.1097/AOG.0000000000004290
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Actual Problems of Pediatrics, Obstetrics and Gynecology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
